Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 8
2005 5
2006 4
2007 6
2008 6
2009 6
2010 9
2011 3
2012 7
2013 7
2014 10
2015 7
2016 7
2017 7
2018 12
2019 10
2020 9
2021 10
2022 5
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
The making of bispecific antibodies.
Brinkmann U, Kontermann RE. Brinkmann U, et al. Among authors: kontermann re. MAbs. 2017 Feb/Mar;9(2):182-212. doi: 10.1080/19420862.2016.1268307. MAbs. 2017. PMID: 28071970 Free PMC article. Review.
Bispecific antibodies.
Brinkmann U, Kontermann RE. Brinkmann U, et al. Among authors: kontermann re. Science. 2021 May 28;372(6545):916-917. doi: 10.1126/science.abg1209. Science. 2021. PMID: 34045345 No abstract available.
The present and future of bispecific antibodies for cancer therapy.
Klein C, Brinkmann U, Reichert JM, Kontermann RE. Klein C, et al. Among authors: kontermann re. Nat Rev Drug Discov. 2024 Apr;23(4):301-319. doi: 10.1038/s41573-024-00896-6. Epub 2024 Mar 6. Nat Rev Drug Discov. 2024. PMID: 38448606 Review.
Bispecific antibodies.
Kontermann RE, Brinkmann U. Kontermann RE, et al. Drug Discov Today. 2015 Jul;20(7):838-47. doi: 10.1016/j.drudis.2015.02.008. Epub 2015 Feb 26. Drug Discov Today. 2015. PMID: 25728220 Free article. Review.
OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models.
Fabre M, Ferrer C, Domínguez-Hormaetxe S, Bockorny B, Murias L, Seifert O, Eisler SA, Kontermann RE, Pfizenmaier K, Lee SY, Vivanco MD, López-Casas PP, Perea S, Abbas M, Richter W, Simon L, Hidalgo M. Fabre M, et al. Among authors: kontermann re. Clin Cancer Res. 2020 Jul 1;26(13):3420-3430. doi: 10.1158/1078-0432.CCR-19-2238. Epub 2020 Mar 11. Clin Cancer Res. 2020. PMID: 32161121
Half-life extended biotherapeutics.
Kontermann RE. Kontermann RE. Expert Opin Biol Ther. 2016 Jul;16(7):903-15. doi: 10.1517/14712598.2016.1165661. Epub 2016 Apr 18. Expert Opin Biol Ther. 2016. PMID: 26967759 Review.
Antibody-cytokine fusion proteins.
Kontermann RE. Kontermann RE. Arch Biochem Biophys. 2012 Oct 15;526(2):194-205. doi: 10.1016/j.abb.2012.03.001. Epub 2012 Mar 16. Arch Biochem Biophys. 2012. PMID: 22445675 Review.
Intrathymic dendritic cell-biased precursors promote human T cell lineage specification through IRF8-driven transmembrane TNF.
Liang KL, Roels J, Lavaert M, Putteman T, Boehme L, Tilleman L, Velghe I, Pegoretti V, Van de Walle I, Sontag S, Vandewalle J, Vandekerckhove B, Leclercq G, Van Vlierberghe P, Libert C, Van Nieuwerburgh F, Fischer R, Kontermann RE, Pfizenmaier K, Doody G, Zenke M, Taghon T. Liang KL, et al. Among authors: kontermann re. Nat Immunol. 2023 Mar;24(3):474-486. doi: 10.1038/s41590-022-01417-6. Epub 2023 Jan 26. Nat Immunol. 2023. PMID: 36703005 Free article.
Co-modulation of TNFR1 and TNFR2 in an animal model of multiple sclerosis.
Fiedler T, Fairless R, Pichi K, Fischer R, Richter F, Kontermann RE, Pfizenmaier K, Diem R, Williams SK. Fiedler T, et al. Among authors: kontermann re. J Neuroinflammation. 2023 Apr 30;20(1):100. doi: 10.1186/s12974-023-02784-z. J Neuroinflammation. 2023. PMID: 37122019 Free PMC article.
140 results